DBVT opened at $6.20 on Friday. DBV Technologies has a 12 month low of $2.20 and a 12 month high of $8.32. The stock has a market capitalization of $127.53 million, a P/E ratio of -1.38 and a beta ...

Clinical-stage biopharmaceutical company DBV Technologies (NASDAQ:DBVT) announced a financing of up to $306.9M (€284.5M), including gross proceeds of $125.5M (€116.3M) to be received upon ...

DBV Technologies secured up to $306.9M to advance its Viaskin Peanut program. The funding supports FDA submission, commercialization and ongoing pediatric peanut allergy treatment research. Learn ...

American depositary receipts of DBV Technologies gained after the company reported new financing of up to $306.9 million. The biopharmaceutical company's ADRs were up 57%, at $6.14, Friday morning.

If you are planning to travel to Dubrovnik or any other city in Croatia, this airport locator will be a very useful tool. This page gives complete information about the Dubrovnik Airport along with ...

NASDAQ:LPCN opened at $3.28 on Friday. The firm has a market cap of $17.55 million, a price-to-earnings ratio of -4.32 and a beta of 1.42. Lipocine has a 52 week low of $2.91 and a 52 week high of ...

Meanwhile, David Schilansky, who previously co-headed DBV Technologies and led two IPOs on Euronext and Nasdaq with more than one billion US dollars raised, became CFO at Ariceum Therapeutics.

Before joining FineHeart, Sébastien Robitaille held strategic roles at DBV Technologies, a French biotech company listed on Euronext and Nasdaq. He successfully led multiple fundraising efforts, ...